BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Business

  Applied Genetic Technologies Corporation And 4D Molecular Therapeutics Sign Collaboration Agreement For Gene Therapy Vector Discovery And Product Development

  April 20, 2015

   · 

  5 min read
• Drug Development

  KEYTRUDA (Pembrolizumab), Merck & Co.’s Anti-PD-1 Therapy, Demonstrates Superior Survival, Progression Free Survival And Overall Response Rate Compared To Ipilimumab An Anti-CTLA-4 Therapy

  April 20, 2015

   · 

  15 min read
• Drug Development

  Early Findings With KEYTRUDA (Pembrolizumab), Merck & Co.’s Anti-PD-1 Therapy, In Patients With Advanced Pleural Mesothelioma Presented At American Association for Cancer Research Annual Meeting

  April 20, 2015

   · 

  12 min read
• Drug Development

  Full Data On Baxter International’s Investigational Recombinant Treatment BAX 111 Supports Potential Role To Treat Von Willebrand Disease

  April 20, 2015

   · 

  5 min read
• Drug Development

  Pluristem Therapeutics’s Clinical Advisory Board Prepares Phase II Clinical Trials In Critical Limb Ischemia In Europe And Japan

  April 20, 2015

   · 

  4 min read
• Drug Development

  Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals, Inc.'s NP001 Potential Efficacy And Safety In ALS

  April 20, 2015

   · 

  7 min read
• Drug Development

  Atara Biotherapeutics’ Collaborating Investigators’ Abstract On T-Cell Therapy For EBV Lymphoma To Be Presented At A Clinical Trials Plenary Session At The American Association for Cancer Research Annual Meeting 2015 Is Now Available

  April 20, 2015

   · 

  4 min read
• Drug Development

  MediWound Initiates U.S. Phase 3 Trial With NexoBrid To Treat Severe Burns

  April 20, 2015

   · 

  5 min read
• Business

  NeoStem, Inc. Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma

  April 20, 2015

   · 

  4 min read
• Drug Development

  Onconova Therapeutics Inc. Submits Pivotal Clinical Trial Protocol For IV Rigosertib In Higher-Risk Myelodysplastic Syndromes To FDA And European Medicines Agency

  April 20, 2015

   · 

  5 min read